Diabetic Live

According to research that was presented at the Experimental Biology Conference in Boston, eating grapes may protect against the damage that is created by the progression of metabolic syndrome. It is the natural components called polyphenols that are thought to bring these beneficial effects.

The study, which was led by chief investigator E. Mitchell Syemour, Ph.D of the University of Michigan Health System included the effects of a high fat, American diet. One study was created with the use of grapes and one was implemented without them. The fat tissue, heart, kidneys, and liver was all studied in obesity-prone rats. Grapes were used in different varieties (green/red/black) and consisted of a freeze-dried grape powder. This powder was integrated into the animal’s diet for 90 days.

Continue reading “Can Grapes Protect Against Metabolic Syndrome-Related Organ Damage?”

Recently, Abbott Laboratories issued a recall on all FreeStyle InsuLink Glucose Meters due to the fact they are displaying and storing incorrect test results for extremely high blood sugar levels.

It is very important for glucose meters to read correctly since it can jeopardize a person’s life who has diabetes. When a diabetic checks their blood sugar, they are making sure that it is not too high. If it is high, they need to treat it immediately. The problem with these meters is that they are not logging the right information, which can lead to injury and/or death.

Continue reading “FreeStyle InsuLinx Glucose Meter Recall”

With all the news about drug therapy, many researchers are beginning to wonder what is being done to stop diabetes from happening in the first place. Studies show, not much.

According to a Duke Medicine study, research for diabetes is far more focused on drug therapy than it is on taking the preventative measures to stop diabetes in its tracks. While also excluding older people and children from gaining better management for the disease.

Continue reading “What Dominates Diabetes Research, Prevention or Drug Therapy?”

According to a study at the Henry Ford Hospital in Detroit, a group of medications that lowers blood sugar in diabetic patients is also helping to protect them against heart failure as well.

Henry Ford researcher and cardiologist David Lanfear, M.D., lead author of the study said, “People with diabetes are at risk for developing heart failure. Diabetic adults die of heart disease two to four times more than those without diabetes.

Continue reading “Type 2 Diabetes Drug Class Reducing Heart Failure”

A common anti-anginal drug has been found to reduce the chest pain that many people with type 2 diabetes suffer from. According to research that was presented to the American College of Cardiology’s 62^nd Annual Scientific Session., the drug also appears to have a more pronounced effect with those who have poorer glucose control.

Continue reading “New Type 2 Diabetes Drug Found To Reduce Chest Pain”

New Jersey Institute for Successful Aging (NJISA) at the University of Medicine and Dentistry of New Jersey (UMDNJ)-School of Osteopathic Medicine’s Robert Nagele, PhD, led a research team that has demonstrated that the anti-atherosclerosis drug darapladib can reduce leaks in the blood brain barrier. These findings open up quite a few possibilities for new drug therapies to prevent the onset of Alzheimer’s disease.

The researchers were able to find this new drug theory through an a study that involved the use of darapladib in animal models that had been stimulated to develop diabetes mellitus and hypercholesterolemia (DMHC), which are both huge risk factors for developing Alzheimer’s disease.

Continue reading “New Diabetic Study Shows Drug Can Slow Alzheimer’s Disease”

According to new research, those who are taking the newest class of diabetic drugs in order to control blood sugar are more likely to become hospitalized with pancreatitis.

Scientists say that the glucagon-like peptide-1-based therapies (GLP-1) of the new drugs is the culprit for the increased risk of hospitalization for acute pancreatitis. Sitagliptin (brand named Janivia) and Extenatide (brand named Byetta) are suggested to contribute to the formation of lesions within the pancreas and the introductions of ducts in the organ. This causes an increased amount of inflammation.

Continue reading “Type 2 Diabetes Medications Causing Pancreatitis”

A trial was conducted by IRCM researchers (led by endocrinologist Dr. Rémi Rabasa-Lhoret) that compared a dual-hormone artificial pancreas with conventional diabetes treatments that use an insulin pump and showed improved glucose levels and lower risks of hypoglycemia.

The results showed that the artificial pancreas can have a huge impact where treatment is concerned for people who have been diagnosed with type 1 diabetes.

Continue reading “Trial Results In On New Artificial Pancreas”

Diabetes itself is growing. It has been for years now. What surprises many people however is to learn that type 1 diabetes among children is growing at a higher rate. In fact, in children aged under five years old, type 1 diabetes has increased by 70 percent in Philadelphia.

Information about diabetes has been collected since 1985 from the University of Pennsylvania.  Researchers led by nursing professor Terri H. Lipman, PhD, RN found that there was an increase in type 1 diabetes in children of 29 percent between the years of 1985 and 2004.

Continue reading “Type 1 Diabetes Has Increased in Urban Children By 70 Percent”